Veradermics Email Format

Pharmaceutical ManufacturingConnecticut, United States11-50 Employees

Veradermics is a late clinical-stage biopharmaceutical company based in New Haven, Connecticut, founded by dermatologists who bring hands-on experience with pattern hair loss. The company concentrates on developing therapies for pattern hair loss, aiming to deliver treatments grounded in real evidence and to raise clarity and reliability in how the condition is managed. Its lead investigational product, VDPHL01, is described as potentially the first non-hormonal oral option for hair regrowth in both men and women.

Pattern hair loss is described as the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years, creating a significant unmet need the company seeks to address. Veradermics operates in the pharmaceutical development space and has publicly shared progress through topline results from a Phase 2/3 study of VDPHL01 and by engaging with investor conferences to discuss upcoming milestones.

Get verified Veradermics emails free

Company overview Employee directory